iACT for PTSD and Chronic Pain
Internet-based Acceptance and Commitment Therapy for PTSD and Chronic Pain
1 other identifier
interventional
40
1 country
1
Brief Summary
The primary aim of this study is to investigate the effect of Internet-delivered Acceptance and commitment therapy for PTSD and comorbid chronic pain using a randomized controlled trial with waitlist control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2021
CompletedStudy Start
First participant enrolled
October 18, 2021
CompletedFirst Posted
Study publicly available on registry
December 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 18, 2027
February 19, 2026
February 1, 2026
5 years
October 8, 2021
February 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PTSD symptom severity as measured by the the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) and the Life Events Checklist (LEC-5)
(changes between assessments)
Baseline, mid-treatment (3 weeks), mid-treatment (7 weeks), two-week-post treatment, 3 month-follow-up, 12-month follow-up.
Secondary Outcomes (14)
Anxiety and depression as measured by the Hospital Anxiety and Depression Scale (HADS)
Baseline, two-week-post treatment, 3 month-follow-up, 12-month follow-up.
Psychological inflexibility as measured by the Psychological Inflexibility in Pain Scale (PIPS)
Baseline, two-week-post treatment, 3 month-follow-up, 12-month follow-up.
General acceptance as measured by the Swedish Acceptance and Action Questionnaire (SAAQ)
Baseline, mid-treatment (3 weeks), mid-treatment (7 weeks), two-week-post treatment, 3 month-follow-up, 12-month follow-up.
Posttraumatic Cognitions as measured by the Posttraumatic Cognitions Inventory (PTCI)
Baseline, two-week-post treatment, 3 month-follow-up, 12-month follow-up.
Pain interference as measured by the Multidimensional Pain Inventory (MPI)
Baseline, two-week-post treatment, 3 month-follow-up, 12-month follow-up.
- +9 more secondary outcomes
Study Arms (2)
Treatment
EXPERIMENTALInternet delivered Acceptance and Commitment Therapy for PTSD and Chronic Pain, supported by a psychologist
Waitlist
NO INTERVENTIONWaitlist for 12 weeks.
Interventions
The participants will go through internet-based Acceptance and Commitment Therapy which mainly involves: 1) Exercises focused on developing acceptance, defusion, and mindfulness skills; 2) Identification of personal values as well as valued steps and feared situations to approach during the program 3) Written exposure exercises focusing on the traumatic memory adapted from Written exposure therapy (WET) using an ACT-based framework. The treatment is delivered on a safe internet platform. Participants have planned telephone contact with their assigned psychologist 3 times during the program and can also contact their psychologist via a message system in the platform and expect answer within 48 hours.
Eligibility Criteria
You may qualify if:
- a CAPS of ≥25
- subjected to single traumatic events
- were able to understand Swedish
- had symptoms of chronic pain that interfered significantly with everyday life
- were fully examined medically and had received medical treatment if indicated
- were able to be an active part of the rehabilitation process, regain functioning in different life areas and participate in treatment interventions for approximately 5 hours every week
- stable dose of medication
- able to read and write in Swedish
- had access to a smart phone or computer with internet access
You may not qualify if:
- repeated and extensive traumatic events
- had other acute or severe psychiatric disorders or symptoms that warranted designation as the primary disorder (ongoing substance dependence, untreated bipolar disorder, OCD, psychotic symptoms, severe depression)
- were actively abusing analgesic medications (including narcotics), alcohol or other drugs
- had great difficulty to harbour and handle strong emotions that could lead to emotional outbursts or self-harming behavior
- had health risks due to medical reasons
- had social or economic difficulties or lack of social support that hindered behavior change
- current severe suicidal ideation that warranted immediate intervention (indicated by the MINI and a score of 3 to item 9 of the Patient Health Questionnaire 9-item version (PHQ9))
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Pain Pehabilitation, Skåne University Hospital
Lund, 22241, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 8, 2021
First Posted
December 7, 2021
Study Start
October 18, 2021
Primary Completion (Estimated)
October 18, 2026
Study Completion (Estimated)
December 18, 2027
Last Updated
February 19, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share